Ribose (Furanose)

Ribose (Furanose)

SCHEMBL502608

CN(C)C(=O)c1cccnc1.OC[C@H]1OC(O)[C@H](O)[C@@H]1O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.43
HSD17B10 Q99714 3/20 0.43
USP2 O75604 1/20 0.43
TP53 P04637 1/20 0.43
ALOX15 P16050 1/20 0.43
MAPK1 P28482 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HTT P42858 1/20 0.43
GAA P10253 2/20 0.40
THRB P10828 1/20 0.40
HK1 P19367 2/20 0.39
HK2 P52789 2/20 0.39
ALDH1A1 P00352 3/20 0.39
APP P05067 1/20 0.39
HCAR3 P49019 1/20 0.39
HCAR2 Q8TDS4 1/20 0.39
MLYCD O95822 1/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP1A2 P05177 1/20 0.38
GLA P06280 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ribose (Furanose) SCHEMBL502577 0.84 ALDH1A1 (0.58) GAATHRBHK1HK2ALDH1A1
Ribose (Furanose) SCHEMBL18185139 0.83 F7 (0.59) TSHRGAATHRBHK1HK2
Ribose (Furanose) SCHEMBL14321532 0.83 F7 (0.59) TSHRGAATHRBHK1HK2
Ribose (Furanose) SCHEMBL338518 0.83 F7 (0.59) TSHRGAATHRBHK1HK2
Methyl Nicotinate SCHEMBL2176622 0.82 ALDH1A1 (0.62) HSD17B10THRBALDH1A1
Ribose (Furanose) SCHEMBL23111913 0.82 F7 (0.58) GAATHRBHK1HK2ALDH1A1
Ribose (Furanose) SCHEMBL17315074 0.81 F7 (0.56) GAATHRBHK1HK2ALDH1A1
Ribose (Furanose) SCHEMBL25392429 0.81 F7 (0.52) GAATHRBHK1HK2ALDH1A1
Ethyl Nicotinate SCHEMBL502614 0.81 L3MBTL1 (0.51) TP53MAPK1ALDH1A1KDM4E
SCHEMBL21137939 0.79 HTT (0.39) TSHRHSD17B10USP2TP53ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11633414-B2 Nicotinoyl riboside compositions and methods of use CORNELL UNIVERSITY (US) 2023-04-25 US disclosed
US-20210353657-A1 NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE CORNELL UNIVERSITY (US) 2021-11-18 US disclosed
US-11077129-B2 Nicotinoyl riboside compositions and methods of use CORNELL UNIVERSITY (US) 2021-08-03 US disclosed
EP-3730507-A1 NICOTINOYL RIBOSIDE AND NICOTINAMIDE RIBOSIDE COMPOSITIONS FOR USE IN REDUCING TOXICITY INDUCED BY HMG-COA REDUCTASE INHIBITORS Cornell Research Foundation, Inc. (US) 2020-10-28 EP disclosed
US-20200289535-A1 NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE CORNELL UNIVERSITY 2020-09-17 US disclosed
US-10668096-B2 Nicotinoyl riboside compositions and methods of use CORNELL UNIVERSITY (US) 2020-06-02 US disclosed
EP-3369738-B1 METHOD FOR MAKING NICOTINOYL RIBOSIDES AND NICOTINAMIDE BETA-RIBOSIDE CORNELL RES FOUNDATION INC (US) 2020-05-20 EP disclosed
US-20190192542-A1 NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE CORNELL UNIVERSITY 2019-06-27 US disclosed
US-10206940-B2 Nicotinoyl riboside compositions and methods of use CORNELL UNIVERSITY (US) 2019-02-19 US disclosed
EP-3369738-A1 NICOTINYL RIBOSIDE COMPOSITIONS AND METHODS OF USE Cornell Research Foundation, Inc. (US) 2018-09-05 EP disclosed
EP-1957086-B1 NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE CORNELL RES FOUNDATION INC (US) 2018-05-02 EP disclosed
US-20160310517-A1 NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE CORNELL UNIVERSITY 2016-10-27 US disclosed
US-9321797-B2 Nicotinoyl riboside compositions and methods of use CORNELL UNIVERSITY (US) 2016-04-26 US disclosed
US-9000147-B2 Nicotyl riboside compositions and methods of use CORNELL UNIVERSITY (US) 2015-04-07 US disclosed
US-20150072950-A1 NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE CORNELL UNIVERSITY 2015-03-12 US disclosed
US-20120172584-A1 NICOTYL RIBOSIDE COMPOSITIONS AND METHODS OF USE CORNELL UNIVERSITY (US) 2012-07-05 US disclosed
US-8106184-B2 Nicotinoyl riboside compositions and methods of use CORNELL UNIVERSITY (US) 2012-01-31 US disclosed
EP-1957086-A2 NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE CORNELL RESEARCH FOUNDATION, INC. (US) 2008-08-20 EP disclosed
WO-2007061798-A2 NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE CORNELL RESEARCH FOUNDATION, INC. (US) 2007-05-31 WO disclosed
US-20070117765-A1 Nicotinoyl riboside compositions and methods of use CORNELL RESEARCH FOUNDATION INC. 2007-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172584-A1 NICOTYL RIBOSIDE COMPOSITIONS AND METHODS OF USE NNT, NAMPT, NAPRT TSHR 4643/4885HSD17B10 2369/4885USP2 4191/4885
US-11077129-B2 Nicotinoyl riboside compositions and methods of use NNT, CD38, NAMPT TSHR 4504/4885HSD17B10 1684/4885USP2 4292/4885
US-20160310517-A1 NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE NADK, NNT, CD38 TSHR 4589/4885HSD17B10 1816/4885USP2 4384/4885
US-20070117765-A1 Nicotinoyl riboside compositions and methods of use NNT, CD38, NAMPT TSHR 4504/4885HSD17B10 1684/4885USP2 4292/4885
US-20190192542-A1 NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE NNT, CD38, NAMPT TSHR 4504/4885HSD17B10 1684/4885USP2 4292/4885
US-20200289535-A1 NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE NNT, CD38, NAMPT TSHR 4504/4885HSD17B10 1684/4885USP2 4292/4885
US-10668096-B2 Nicotinoyl riboside compositions and methods of use NNT, CD38, NAMPT TSHR 4504/4885HSD17B10 1684/4885USP2 4292/4885
US-20210353657-A1 NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE NNT, CD38, NAMPT TSHR 4504/4885HSD17B10 1684/4885USP2 4292/4885
US-20150072950-A1 NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE NNT, CD38, NAMPT TSHR 4504/4885HSD17B10 1684/4885USP2 4292/4885
US-11633414-B2 Nicotinoyl riboside compositions and methods of use NNT, CD38, NAMPT TSHR 4504/4885HSD17B10 1684/4885USP2 4292/4885
US-10206940-B2 Nicotinoyl riboside compositions and methods of use NADK, NNT, CD38 TSHR 4589/4885HSD17B10 1816/4885USP2 4384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.